STOCK TITAN

Employee in TSHA (Nasdaq: TSHA) plans Rule 144 sale of 30,052 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of TSHA common stock has filed a notice of proposed sale under Rule 144. The filing covers 30,052 shares of common stock to be sold through Maxim Group LLC on the Nasdaq, with an aggregate market value of $152,964.68. The filing notes that 273,919,373 shares of this class were outstanding at the time of the notice.

The shares to be sold were acquired on 01/23/2026 as a restricted stock unit (RSU) award from the issuer. The RSUs vested and were settled in stock on that date, with the consideration described as the reporting person’s continued service as an employee of the issuer. The signer also represents they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many TSHA shares are planned for sale under this Form 144?

The notice covers the proposed sale of 30,052 shares of TSHA common stock.

What is the aggregate market value of the TSHA shares to be sold?

The aggregate market value of the shares covered by the notice is $152,964.68.

Through which broker and exchange will the TSHA shares be sold?

The planned sale is through Maxim Group LLC on the Nasdaq exchange.

When were the TSHA shares being sold acquired and how?

The common stock was acquired on 01/23/2026 via an RSU award from the issuer, which vested and was settled in stock as compensation for the reporting person’s continued employment.

How many TSHA common shares were outstanding when this notice was filed?

The filing reports 273,919,373 shares of TSHA common stock outstanding for this class at the time of the notice.

Does the seller make any representation about undisclosed negative information on TSHA?

Yes. By signing, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

Taysha Gene Therapies, Inc.

NASDAQ:TSHA

TSHA Rankings

TSHA Latest News

TSHA Latest SEC Filings

TSHA Stock Data

1.39B
242.89M
11.15%
94.76%
14.95%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
DALLAS